SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 323 filers reported holding SEATTLE GENETICS INC in Q3 2019. The put-call ratio across all filers is 1.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $8,509,000 | +5.5% | 44,104 | -8.7% | 0.02% | 0.0% |
Q2 2020 | $8,066,000 | +58.3% | 48,317 | +9.3% | 0.02% | +38.5% |
Q1 2020 | $5,095,000 | -25.4% | 44,221 | -26.1% | 0.01% | 0.0% |
Q4 2019 | $6,834,000 | -13.0% | 59,865 | -39.2% | 0.01% | -13.3% |
Q3 2019 | $7,855,000 | +4.3% | 98,432 | -11.0% | 0.02% | +7.1% |
Q2 2019 | $7,528,000 | -11.7% | 110,570 | -6.1% | 0.01% | -12.5% |
Q1 2019 | $8,527,000 | +27.3% | 117,766 | -1.3% | 0.02% | +6.7% |
Q4 2018 | $6,700,000 | -22.6% | 119,303 | +7.4% | 0.02% | -6.2% |
Q3 2018 | $8,661,000 | +31.6% | 111,038 | +9.9% | 0.02% | +14.3% |
Q2 2018 | $6,580,000 | -27.2% | 100,994 | -41.5% | 0.01% | -6.7% |
Q1 2018 | $9,037,000 | -16.0% | 172,718 | -11.6% | 0.02% | -16.7% |
Q4 2017 | $10,759,000 | -15.7% | 195,489 | -16.7% | 0.02% | -18.2% |
Q3 2017 | $12,766,000 | -4.7% | 234,630 | -9.4% | 0.02% | -8.3% |
Q2 2017 | $13,396,000 | -23.8% | 258,898 | -7.4% | 0.02% | -25.0% |
Q1 2017 | $17,582,000 | +53.0% | 279,698 | +29.9% | 0.03% | +45.5% |
Q4 2016 | $11,492,000 | – | 215,246 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 44,100,294 | $2,381,857,000 | 21.61% |
Lagoda Investment Management, L.P. | 567,057 | $30,627,000 | 9.21% |
Redmile Group, LLC | 1,781,470 | $96,217,000 | 7.65% |
Boxer Capital, LLC | 232,600 | $12,563,000 | 5.63% |
NEXTHERA CAPITAL LP | 111,500 | $6,022,000 | 3.70% |
Eventide Asset Management | 835,506 | $45,126,000 | 2.76% |
WASATCH ADVISORS LP | 2,844,908 | $153,653,000 | 2.29% |
Opus Point Partners Management, LLC | 67,953 | $3,670,000 | 2.06% |
CORRADO ADVISORS, LLC | 43,050 | $2,325,000 | 1.48% |
Baillie Gifford | 16,795,793 | $907,142,000 | 1.42% |